Lytix Biopharma attends ESMO in Madrid, Spain, Sept. 26-30, 2014
ESMO (EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY)
Lytix Biopharma will be represented by Wenche Marie Olsen (COO), Berit Nicolaisen (Project Manager, Oncology) and Frode Bjerkely (Clinical Study Manager) at ESMO, the largest medical oncology Conference in Europe.